Group 1 - Alkermes plc will host a conference call and webcast presentation on May 1, 2024, at 8:00 a.m. ET to discuss its first quarter financial results [1] - The webcast and accompanying slides will be available on the Investors section of Alkermes' website [1] - A replay of the webcast will be accessible approximately two hours after the event [1] Group 2 - Alkermes plc is a global biopharmaceutical company focused on developing innovative medicines in neuroscience [2] - The company has a portfolio of proprietary products for treating alcohol dependence, opioid dependence, schizophrenia, and bipolar I disorder [2] - Alkermes has research and development facilities in Waltham, Massachusetts, and manufacturing facilities in Athlone, Ireland, and Wilmington, Ohio [2]
Alkermes to Report First Quarter Financial Results on May 1, 2024